Last Friday, Spectra7 Microsystems (Spectra7 Microsystems Stock Quote, Chart, News: TSXV:SEV) announced that the company’s CEO Tony Stelliga had died suddenly.
“We are greatly saddened by Tony’s passing, ” said chairman Ronald Pasek. “The board and the company are indebted to Tony for his strong leadership, boundless energy and dedication, and significant contribution to Spectra7 during his tenure. The board’s thoughts are with Tony’s family at this very difficult time.”
The company announced that CFO Dave Mier and VP general counsel and corporate development Cynthia Cole had been appointed to oversee the company on an interim basis until a new CEO can be found.
Garcea says it is the duty of those who remain with Spectra7 to carry out his vision, and the analyst believes it is a task they will honour.
“It is with our deepest regrets to publish on such sad news; however in Tony’s honour, SEV’s vision must live on. Tony was a great visionary and full of passion and drive. Just as he started putting all the pieces of the puzzle together for SEV, he suddenly and unexpectedly passed away,” said Garcea. “We are confident in the ability of SEV’s Board to appoint a CEO with deep roots in the semiconductor industry and one that is capable of delivering on Tony’s vision.”
In a research update to clients today, Garcea maintained his “Buy” rating one-year price target of $1.25 on Spectra7 Microsystems, implying a return of 127 per cent at the time of publication.
Its fourth quarter results are in the books and Ventum Capital Markets analysts Andrew Semple has raised his price target… [Read More]
It's just getting started. That's the takeaway from new coverage of HEALWELL AI (HEALWELL AI Stock Quote, Chart, News, Analysts,… [Read More]
Following the company's fourth quarter results, Scotia analyst Konark Gupta has raised his price target on MDA (MDA Stock Quote,… [Read More]
Following the company's fourth quarter results, National Bank Financial analyst Richard Tse has raised his price target on Constellation Software… [Read More]
Following the company's fourth quarter results, Ventum Capital Markets analyst Andrew Semple has downgraded and cut his price target on… [Read More]
Following the company's third quarter results, Ventum Capital Markets analyst Amr Ezzat has maintained his "Buy" rating and "Top Pick"… [Read More]